Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT-P27 efficacy and safety in an influenza challenge model (healthy volunteers)
2013-004544-32Phase 2Completed
- Sponsor
- Celltrion
- Start
- Dec 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in influenza comparing CT-P27 arm with Placebo arm (2 arms). Primary endpoint: Primary: AUC of nasopharyngeal viral load. Started Dec 2013; status: completed.
02
Drugs
CT-P27
03
Conditions
influenza
Beyond the preview
Go deeper on 2013-004544-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004544-32.